Winton Group LTD Elanco Animal Health Inc Transaction History

Winton Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$12.93 - $18.45 $238,933 - $340,937	18,479 New	18,479 $266,000
Q2 2021 Aug 10, 2021	SELL	$28.76 - $35.98 $404,538 - $506,094	-14,066 Closed	0 $0
Q1 2021 Jul 21, 2021	BUY	$27.85 - $34.49 $92,267 - $114,265	3,313 Added 30.81%	14,066 $414,000
Q4 2020 Feb 12, 2021	BUY	$27.53 - $33.79 $296,030 - $363,343	10,753 New	10,753 $330,000
Q3 2020 Oct 30, 2020	SELL	$21.1 - $29.13 $3.24 Million - $4.48 Million	-153,630 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$18.94 - $24.93 $907,453 - $1.19 Million	-47,912 Reduced 23.77%	153,630 $3.3 Million
Q1 2020 May 11, 2020	SELL	$16.68 - $32.25 $1.34 Million - $2.59 Million	-80,257 Reduced 28.48%	201,542 $4.51 Million
Q4 2019 Feb 13, 2020	BUY	$25.29 - $29.45 $7.13 Million - $8.3 Million	281,799 New	281,799 $8.3 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.